Rehabilitative effects of Baduanjin in Chinese stroke patients: A systematic review and <i>meta</i>-analysis

Author: Xi Cheng1,2, Yanling Gao1,2, Xiaofeng Chen1,2, Jinhua Lu1,2, Qingyue Dai1,2, Jinghui Lai1,2
1 Rehabilitation Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350003, China.
2 Fujian Key Laboratory of Rehabilitation Technology, Fuzhou, Fujian 350003, China.
Conference/Journal: Prev Med Rep
Date published: 2024 Apr 4
Other: Volume ID: 41 , Pages: 102703 , Special Notes: doi: 10.1016/j.pmedr.2024.102703. , Word Count: 215

This study aims to systematically assess the rehabilitative effects of Baduanjin in stroke patients.

Ten electronic databases were systematically searched using MeSH and free terms for relevant studies written in the English or Chinese language, and published on or before 15 February 2023. Studies in which Baduanjin was the only difference in treatment administered to experimental and control groups were included in the review. The studies' risk of bias was evaluated using the Cochrane criteria.

Twenty one studies that involved 1,649 participants were included. Compared to the control group, Baduanjin increased the scores for the Fugl-Meyer Assessment (including both upper and lower extremity components), Berg Balance Scale, Trunk Impairment Scale, Functional Ambulation Categories, 6-minute Walking Distance, Modified Barthel Index, Barthel Index, and total effective rate, but reduced the scores for the Pk254 balance function detection system, National Institutes of Health Stroke Scale and neurological deficit scale (P < 0.05, for all).

The present study findings revealed the potential benefits of Baduanjin in improving movement, balance, trunk, ambulation and neurological functions, and the ability to perform activities of daily living in stroke patients. Larger randomized controlled trials with more standardized intervention protocols are required to obtain more robust evidence.

Keywords: Baduanjin; Meta-analysis; Randomized controlled trials; Rehabilitative effects; Stroke; Systematic review.

PMID: 38595729 PMCID: PMC11002574 DOI: 10.1016/j.pmedr.2024.102703